CRA International, Inc.

  • Market Cap: Small Cap
  • Industry: Miscellaneous
  • ISIN: US12618T1051
USD
187.82
4.63 (2.53%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About CRA International, Inc. stock-summary
stock-summary
CRA International, Inc.
Miscellaneous
CRA International, Inc. is a global consulting firm. The Company provides economic, financial and management consulting services. The Company consulting services in two areas: litigation, regulatory, and financial consulting and management consulting. The Company provides services, such as economic capability, analyses and testimony in areas, such as Antitrust & Competition; Damages & Valuation; Financial Accounting & Valuation; Financial Economics; Forensic & Cyber Investigations; Insurance Economics; Intellectual Property; International Arbitration; Labor & Employment; Mergers & Acquisitions; Regulatory Economics & Compliance; Securities & Financial Markets, and Transfer Pricing. It offers management consulting in the areas, including Auctions & Competitive Bidding; Corporate & Business Strategy; Enterprise Risk Management; Environmental & Energy Strategy; Intellectual Property & Technology Management; Organization & Performance Improvement, and Transaction Advisory Services.
Company Coordinates stock-summary
Company Details
200 Clarendon St , BOSTON MA : 02116-5021
stock-summary
Tel: 1 617 4253000
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 61 Schemes (35.42%)

Foreign Institutions

Held by 85 Foreign Institutions (16.76%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
Dr. Rowland Moriarty
Independent Non-Executive Chairman of the Board
Mr. Paul Maleh
President, Chief Executive Officer, Director
Mr. Thomas Avery
Independent Director
Mr. Richard Booth
Independent Director
Mr. William Concannon
Independent Director
Ms. Christine Detrick
Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
187 Million
(Quarterly Results - Jun 2025)
Net Profit:
12 Million
stock-summary
Industry

Miscellaneous

stock-summary
Market cap

USD 1,270 Million (Small Cap)

stock-summary
P/E

25.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.61

stock-summary
Return on Equity

28.60%

stock-summary
Price to Book

6.45